Verisante launches rapid Raman spectroscopy system for cancer research, other markets
Cancer detection technology developer Verisante (Vancouver, BC, Canada) has launched its VRS rapid Raman spectroscopy system designed for skin and lung cancer detection and research, among other research areas.
Related: Verisante, Clarion Medical Technologies enter distribution agreement